Skip to main content

Table 3 Univariate and multivariate analyses of prognostic factors for disease-specific survival of CRC patients in the study cohort

From: Upregulation of NETO2 expression correlates with tumor progression and poor prognosis in colorectal carcinoma

Variables

Categories

Univariate analysis

Multivariate analysis

  

HR

95 % CI

P valuea

HR

95 % CI

P valuea

Age (years)

≥60/<60

1.674

1.098-2.551

0.017

1.875

1.225-2.871

0.004

Sex

Male/female

1.141

0.791-1.646

0.480

   

Tumor location

Colon/rectum

0.960

0.674-1.367

0.820

   

Tumor size (cm)

≥5/<5

1.161

0.807-1.672

0.421

   

No. of examined lymph nodes

≥12/< 12

0.952

0.669-1.354

0.783

   

Bowel obstruction/perforation

Yes/no

0.962

0.355-2.607

0.940

   

Adjuvant chemotherapy

Yes/no

1.246

0.851-1.825

0.259

   

Differentiation grade

Poor well + moderate

1.691

1.103-2.591

0.016

   

TNM stage

III/I+ II

1.832

1.286-2.609

0.001

1.878

1.313-2.685

0.001

NETO2 expression

High/low

1.986

1.343-2.937

0.001

1.924

1.300-2.848

0.001

  1. Abbreviations: HR, hazard ratio; 95 % CI, 95 % confidence interval
  2. aBold type indicates statistical significance